Search

U.S. Health Secretary Robert F. Kennedy Jr. is proposing initiatives to reduce the use of widely prescribed selective serotonin reuptake inhibitors (SSRIs) despite the department denying discussions about banning them, amidst ongoing debates about their overprescription and links to withdrawal challenges and violence, while emphasizing the need for better research and support for patients. #MentalHealth #Pharmaceuticals #Antidepressants #US

Health Secretary Robert F. Kennedy Jr. has announced initiatives aimed at reducing the overprescription of selective serotonin reuptake inhibitors (SSRIs) in the U.S., promoting nonpharmaceutical interventions and enhancing support for patients seeking to discontinue these psychiatric medications, amidst ongoing debates about their accessibility and the nuances of withdrawal symptoms. #MentalHealth #PsychiatricMedication #Deprescribing #US #GB #DE

Health Secretary Robert F. Kennedy Jr. announced new initiatives aimed at reducing the prescription of psychiatric medications, particularly selective serotonin reuptake inhibitors (SSRIs), by encouraging clinicians to consider alternative treatments and support patients in tapering off these medications, while acknowledging ongoing debates about the appropriate balance of prescribing practices in mental health care. #MentalHealth #Psychiatry #Deprescribing #US #GB #DE

Health Secretary Robert F. Kennedy Jr. has announced new initiatives aimed at reducing the prescription of selective serotonin reuptake inhibitors (SSRIs) in response to concerns about overuse and withdrawal difficulties, emphasizing a shift towards nonpharmaceutical interventions and ensuring patients have better support in managing their mental health treatment. #MentalHealth #Psychiatry #Deprescribing #US #GB #DE

Health Secretary Robert F. Kennedy Jr. has introduced new initiatives aimed at reducing the prescription of selective serotonin reuptake inhibitors (SSRIs) in the U.S., promoting alternative treatments and involving clinicians more in guiding patients through discontinuation, amidst concerns of overprescription and withdrawal symptoms associated with these widely used antidepressants. #MentalHealth #Psychiatry #Overmedication #US #GB #DE